We are glad to invite you to the WorldCongresson Bacteriology and InfectiousDiseases going to commence from November 21-22, 2019 at Singapore, which anticipates more than 500 participants around theworld with thought provoking Keynote lectures, Oral talks and Posterpresentations, Symposia, Workshops.
This two days is your bestopportunity to reach the largest assemblage of participants from bacteriologycommunity especially from academia, microbiology entities, medical groups,labs, related associations, societies and from government agencies, pharmaceutical,biomedical and medical device industries. We will be delighted and honoured bygathering professionals under one roof with the theme of "RecentAdvances and Breakthrough in Bacterialand Fungalinfections".
Bacteriology has a great scope inMedical, R&D, agriculture as well as in industries. Vaccines, antibiotics, drugs,fermented products, beverages, metabolites from bacteria, organic acidsproduction relies on the Bacteriologyand Industrial Microbiology. Our gratitude towards people who are concernedabout bacteriology, bacterial pathogenesis, raising Infectious diseasesAntibiotics and vaccines production and we cordially invite them to gear up andmake the congress a unforgettable successful event.
Bacteriology 2019 cordially invite you to attend the World Congress on Bacteriology and Infectious Diseases slated on November 21-22, 2019 at Singapore. We welcome all scientists, scholars, students, industrialists to attend and explore their knowledge in the field of bacteriology and infectious diseases.
The main topics to be discussed are advances in bacterial genetics, infectious disease, bacterial molecular biology, epidemics, medical bacteriology, industrial microbiology, food industries, and immunology. This conference is an amalgamation of industrialists, academia where they can gear up knowledge in the field of bacteriology.
The central aim of the conference is to share knowledge and to enlighten about novel advancements, anticipate problems in the field of Bacteriology from Emeritus Professors, Eminent Scientists, Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Experts in the field of Microbiology and Bacteriology , Research Scholars, Industrial Delegates and Student Communities in the relevant fields.
Target Audience for Bacteriology and Infectious Diseases conference will include audience from both industrial and academic fields. Directors/Managers, Presidents/Vice Presidents, CEO, Professors,Associate and Assistant professors, Research Scholars, Students, Laboratory Technicians and other members from the related field.
Why To Attend
This bacteriology and infectious diseases conference includes colossal subjects on bacteriology, microbiology in conjunction with infectious diseases caused by bacteria, proteomics, biomarkers and other arguments related to bacteriology diagnostic techniques. The desideratum of this conference is to bolster research and knowledge on Bacteriology and Infectious Diseases. The metamorphosis using bacteriology is expected to reach $16 Billion by the year 2020 and the expense of Diagnosis of Infectious Diseases will reach$7 Billion by the year 2018. This Conference harvests a podium will for a monumental opportunity to know about state-of- the-heart orientations in Bacteriology and Infectious Diseases. A matrix can be created between research scholars of diverse streams such as Bacteriology, Microbiology, Biochemistry where they congregate in a single conference of Bacteriology.
Session on: Bacteriology
Prokaryotes are classified intotwo categories namely Archea and Bacteria. The difference between two ispeptidoglycan layer and N-formyl methionine. The study of domain bacteria isknown as Bacteriology.Bacteria which is not visible to the naked eye is found everywhere in theenvironment. Bacteriology includesbacteria classification, parasitology, epidemiology, infections caused bybacteria, exotoxins of gram-positive bacteria, endotoxins of gram-negativebacteria, genetics and ecology of bacteria. Over past decades Bacteriologyresearch has advanced rapidly.
Related Conferences: 11th World Congress on Virology and Infectious Diseases, May17-18, 2018 at Tokyo, Japan | 3rd International Conference onApplied Microbiology and Beneficial Microorganisms, June6-7, 2018 at Osaka, Japan | 12th Annual Meet on Bacteriology and Microbiology, August 20-21,2018 at Singapore | 11th Global Infections DiseasesConference, July 26-27, 2018 at Melbourne, Australia
Related Associations & Societies: Italian Society onMicrobiology | Federation of EuropeanMicrobiology Societies | European MolecularBiology Organization | Swiss Society forInfectious Diseases | InterregionalAssociation for Clinical Microbiology and Antimicrobial Chemotherapy
Session on: Emerginginfectious diseases
Occupational epidemiology playsan important role in the occurrence of diseases. Some bacterial infectionscaused by Leptospira, Borelliaburgdorferi, Streptococcal species are contagious. Bacterialpathogenesis deals with host-pathogen interactions which are of great use infinding a cure for many diseases.
Related Conferences: 4th International Conference on SexuallyTransmitted Diseases, June 19-20, 2017 at UK | 6th International Conference onLung Cancer and COPD,June 17-18, 2019 at Dublin , Ireland | 4th RareDiseases Conferences, June 11-12, 2018 at Dublin, Ireland | 5th InfectiousConferences, March 1-2, 2018 at Berlin, Germany
Related Associations & Societies: InternationalSociety for Infectious Diseases| EuropeanSociety for Pediatric Infectious Diseases | Society for AppliedMicrobiology| European Society for clinicalvirology
Session on: Epigenomicsof Infectious diseases
Epigenetic events like DNAmethylation and histone modification affects the geneexpression. The pathogenic bacteriadisrupt this epigenetic event. Study of epigenetic alterations helps to knowabout incubation period, incidence, prevalence, attack rate, sporadic,infestation, transmission probability ratio. Based on the study the disease canbe categorized into the epidemic, endemic.
Related Conferences: 10th Virology conferences, July02-04, 2018 at Vienna, Austria| Microbiology PhysiologyConference, July 16-18, 2018 at London, UK | Microbial BiotechnologyConferences, September 17-18, 2018 at Lisbon, Portugal | 11th Medical Microbiologyconferences, July 19-21,2018 at Rome, Italy | 13th Microbial Interactionsconferences, August 2-4, 2018 at Barcelona, Spain
Related Associations & Societies: European Federation ofBiotechnology | Federation of EuropeanMolecular organization | European MolecularBiology Organization | Society for AppliedMicrobiology | Swiss Society forInfectious Disease | European MolecularBiology Organization
Session on: BacterialBiochemistry
It comprises biochemicalreactions in bacteriagrowth, its emphasis on bacterial cell structure, the interaction of biologicalmacromolecules like carbohydrates, lipids, nucleic acids and about thecatabolite repression, proximal control elements, attenuation. Based on thethickness of peptidoglycan layer the bacteriahave been characterized into gram-positive which consists of lipopolysaccharideand gram-negative which consists of teichoic acids. Study of bacterial biochemistry madeadvances in biotechnology industries. This laid down for the invention of newdrugs for infectiousdiseases caused by bacteria.
Related Conferences: 2nd Medical Parasitologyconferences, September 18-19, 2017 at Zurich, Switzerland | 4th Influenza Conferences, July2-3, 2018 at Vienna, Austria |10th Virology Conferences, July2-4, 2018 at Vienna, Austria | 11th Medical MicrobiologyConferences, July 19-21, 2018 at Rome, Italy | 4th Rare Diseases Conferences,June 11-12, 2018 at Dublin, Ireland | 13th Microbial Interactionsconferences, August 2-4, 2018 at Barcelona, Spain | 20th InternationalConference on ClinicalMicrobiology and Infectious Diseases, May 14 - 15, 2018 at London, United Kingdom |10th virology conference, July 02-04,2018 at Vienna, Austria.
Related Associations & Societies: Society for AppliedMicrobiology | Swiss Society for InfectiousDiseases | EuropeanSociety of Clinical Microbiology | InternationalUnion of Microbiology | EuropeanFederation of Biotechnology | InterregionalAssociation for Clinical Microbiology and Antimicrobialchemotherapy
Session on: Bacterialgenomics
Currently, bacterialsequencing has a profound impact on the field of genomics.Based on the short gun sequencing approach the sequences of Leptospirilum,H.influenza is available on biological databases. This deals with hereditaryinformation about bacteria,theta replication, transcription Genome informationassists in Linkage mapping and genetic mapping. Genomics of bacteria alsoincludes phenomenon like Pleiotropy, epistasis. Colonizationof bacteria is based on Virulence factors, currently, genome editing tools likeCRISPR/Cas were available for genomesequencing of bacteria.
Related Conferences: 11th World Congress on Virology and Infectious Diseases, May17-18, 2018 at Tokyo, Japan | 3rd International Conference on AppliedMicrobiology and Infectious Diseases, June6-7, 2018 at Osaka, Japan | 2nd Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia | 12th Annual Meet on Bacteriology and Applied Microbiology, August20-21, 2018 at Singapore
Related Associations & Societies: EuropeanSociety for Human Genetics | Epigenomenetwork of Excellence | South EasternAssociation for Clinical Microbiology | Federation of AmericanSocieties for Experimental Biology | The AmericanAssociation of Immunologists | The AmericanSociety for Clinical Investigation
Session on: ClinicalBacteriology
The main aim of clinicalbacteriology is to diagnose the disease by using specimens. These specimens maybe urine, feces, body fluids, tissue etc. Manual testing is done by using thisspecimen to find out the infectious disease. The infectious diseases weremainly caused by the bacterialike s.pneumonia, h.pylori, t.palladium, l.borreliosis. Medical bacteriology concernsof detection, prevention of infectious disease and to study the characteristicof the pathogen
Related Conferences: 2nd Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia|11th Medical Microbiologyconferences, July 19-21,2018 at Rome, Italy | 2nd International Conference on Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia | 12th Annual Meet on Bacteriology and Infectious Diseases, August20-21, 2018 at Singapore
Related Associations & Societies: Canadian of MedicalMicrobiology | EuropeanFederation of Biotechnology | EuropeanSociety of Clinical Microbiology and Infectious Diseases
Session on: Food bacteriology
It is a combination of manytopics like food preservation, food spoilage, molecular food, fermented foodtechnology, brewing microbiology. Bacteria metabolism shows the impact on food odour,colour, taste, pH changes, slime layer formation. In addition to pathogenicbacteria, there are beneficialbacteria which boosts up an immune system like Probiotics, Prebiotics. Intake ofadequate amounts of probiotic food confers good health. Probiotic bacteriainclude Lactobacillus, Bifidobacterium boosts the immune system.
Related Conferences: 2nd International Conference onFood Safety and Hygiene,March 7-9, 2019 at London, UK | 4th International Conference onFood Science and Technology,April 8-9, 2019 at Zurich, Switzerland | 4th International Conference onFood Chemistry and Technology,July 22-23, 2019 at Brussels, Belgium
Immunityis of two types namely innate and adaptive immunity. Humans immune systemproduces micro-inflammation against host invading body. Immunogenetics dealswith the study of the interrelation of autoimmune disorders, infectious diseases. Basedon previous studies on skin infections it has been found that bacteriais cause for hypersensitivity reactions. The effect of the pathogen on hostdepends upon the virulence factors. Bacteriaacts as an antigen to the human immune system and bacterial peptides undergoexocytosis get attached to MHC-II.
Related Conferences: 9th Molecular Immunology and Immunogenetics Congress, March08-09, 2018 at London, UK | Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia |12th Annual Meet on Bacteriology and Applied Microbiology, August20-21, 2018 at Singapore
Session on: Synthetic Biology
It deals with many disciplinessuch as Genetics,MolecularBiology, Genetic Engineering. Synthetic biology laid down the path formaking of biosensors,synthetic DNA, synthetic transcription factors, biocomputers, industrialenzymes, mass spectrometry. It concerns about design and construction ofcomponents like genetic circuits, metabolicpathways etc. Metabolic profiling, Large-scale integration, quantitativeand integrative proteomics is designed based on the systems biology.
Related Conferences: 4th International Conference on SyntheticBiology and TissueEngineering, June 11-12, 2018 at Rome, Italy | 3rd International Conference onBiomaterials, Cellularand TissueEngineering, June 19-20, 2019 at Dublin, Ireland | International Conference onBiomarkers, March 11-12, 2019 at London, UK
Session on: Bioterrorism
The release of biological agentsintentionally which are contagious like anthrax, botulinum toxin, bubonicplaque. Category A, B, C agents are used for bioterrorism. Forensic microbiology isused along with forensic anthropology for DNA profiling, VNTR markers. A surveyclaimed that revenue spends on the research of bioterrorismwas USD 141.2 million approximately.
Related Associations & Societies: South EasternAssociation for Clinical Microbiology | Federation of AmericanSocieties for Experimental Biology | The AmericanAssociation of Immunologists
Session on: PhytoBacteriology
It deals with pathogens thateffects the plants, plant-bacteria interactions, biofertilizers. Some bacteriafix nitrogen to the root nodules. Agrobacterium tumefaciens is usedas a natural genetictool to insert the plasmid. Phyto bacteriology focuses mainly on taxonomy andpathogenicity factors. Recent research on phytobacteriology includes theantagonistic activity of microorganism against bacterial infections,intracellular bacteria liberobacter, nucleation of bacteria in the activebundles of plants, nonparasitic rhizobacterium.
Related Conferences: 3rd International Conference on AppliedMicrobiology and Infectious Diseases, June6-7, 2018 at Osaka, Japan | 2nd Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia | 12th AnnualMeet on Bacteriology and Applied Microbiology, August20-21, 2018 at Singapore | 11th Global Infections Conference, July26-27, 2018 Melbourne, Australia
Related Associations & Societies: EuropeanFederation of Biotechnology | Federation of EuropeanMolecular organization | Society for AppliedMicrobiology | Swiss Society for InfectiousDisease | European MolecularBiology Organization
Bacteria are used toproduce organic acids, amino acids, industrial enzymes, aminoglycosides,beta-lactam antibiotics. In diary industry, brewing industry bacteria helps tofermentation. Bacteria produce secondary metabolites during the stationarygrowth phase which have great potential in industries.
Related Conferences: 16th Pharmaceutical MicrobiologyConferences, May 21-23, 2018 at Vienna, Austria | 10thAdvanced Microbiologyconferences, June 14-16, 2018 at London, UK | International Conference on Clinical and Pharmaceutical Microbiology,October 18 - 20, 2017 at Rome, Italy | Bacteriology Conferences,June 18-19, 2018 at Paris, France | 2nd Medical Parasitologyconferences, September 18-19, 2017 Zurich
Related Associations & Societies: Society for IndustrialMicrobiology and Biotechnology | Society for AppliedMicrobiology | Swiss Society for InfectiousDiseases | EuropeanSociety of Clinical Microbiology | InternationalUnion of Microbiology
Session on: Vaccines
vaccinesresemble the organism which causes disease and it imbibes the active acquiredimmunity. It is generally the inactivated form of the organism. BioThrax,Daptaceal, Infranix, Pediarix were the new vaccines.The leading companies in drug production are Thermo Fisher scientific,Biomerieux, Dickinson and company, Bio-Rad. The current research was going on DNAand synthetic vaccines, combination and conjugate vaccine, edible vaccines.
Related Conferences: 29th International Conference on Vaccines and Immunization, March19-20,2018 at London, UK | 3rd International Conference on AppliedMicrobiology and Infectious Diseases, June6-7, 2018 at Osaka, Japan | 2nd Medical and Clinical Microbiology, July16-17, 2018 at Melbourne, Australia
Related Associations & Societies: SouthernCalifornia Branch of the American Society for Microbiology | SouthEastern Association for Clinical Microbiology | Federation of AmericanSocieties for Experimental Biology | The AmericanAssociation of Immunologists | The AmericanSociety for Clinical Investigation
Session on: NovelAntibiotics
Antibiotics are those which actagainst the growth of infectiousorganisms. Antimicrobials, antibacterials fall under this. Antibacterialmay be either bacteriostat or bacteriocidal. Bacteriostatis those which inactivates the organism and retards the growth whereas bactericidalcompletely kills the organism. Antibiotics which acts on the specific bacterialgroup were named as narrowspectrum and those which shows activity against two groups i.epositive and negative bacteria are named as broad-spectrum antibiotics.
Related Conferences: 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance, June14-15, 2018 at Barcelona, Spain | 16th Congress on Pharmacology and Clinical trails, September10-11, 2018 at Zurich, Switzerland | 9th European Immunology Conference,June 14-16, 2018 at Rome, Italy
Related Associations & Societies: World Alliance AgainstAntibiotic Resistance (WAAAR) | BEAM Alliance(Biotechs from Europeinnovating in anti-microbial resist | Alliance forthe Prudent Use of Antibiotics (APUA) | Centers for DiseaseControl and Prevention (CDC)
The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020 (BCC research Report).
The use of antimicrobial agents in food-producing animals has recently become a very important public health issue. The Middle-East & Africa market for anticoccidial drugs is estimated to grow from $163.1 million in 2015 to $218 Million by 2020 at a CAGR of 5.95% The Middle-East & Africa anticoccidial drugs market is classified based on various types of animals and by type of antibiotics.
The region, especially countries like Saudi Arabia and Egypt, has increased its reliance on antibiotics
The global market for infectious disease treatments totalled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022. The global market for therapeutics in infectious disease treatments totalled $48.9 billion in 2017. The market should total $74.4 billion by 2022, growing at a CAGR of 8.7% from 2017 to 2022.
The global market for vaccines in infectious disease treatments totalled $8.5 billion in 2017. The market should total $14.4 billion by 2022, growing at a CAGR of 11.2% from 2017 to 2022.
This report on infectious diseases provides global market and forecast trends through 2022. The report provides the total addressable market, an indication of the number of people affected, current share of key marketed therapies, approved and used for the treatment of these diseases, along with forecast by region
The market size of global Bacteriology and Microbiology was estimated to be USD 3.38 billion in 2016. in a recent research study, the market size in 2017 is US$ 153.55 BN and it was estimated to reach US$ 238.69 BN by 2025.
The market size of global Bacteriology and
Microbiology was estimated to be USD 3.38 billion in 2016. in a recent research
study, the market size in 2017 is US$ 153.55 BN and it was estimated to reach
US$ 238.69 BN by 2025.
America has the largest share of 42% in the global microbiology market at $1485.02 million in 2013 and is expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
Next, to America, Europe occupies
the 2nd largest market position. Germany commanded the largest share 20% at an
estimated $223.7 million in 2013 and is expected to reach $272.5 million by the
year 2018, at a CAGR of 4.2% from 2013 to 2018. Europe market size is estimated
to grow by 25% in drugs production against infectious disease from 2014-2022.
France, Germany, Italy together share 80% of Europe vaccines market
Asian Microbiology market is developing rapidly and will continue to grow in future.
China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by the year 2018, at a CAGR of 14.2% from 2013 to 2018.
A recent survey claimed that antibiotics market size is expected to reach USD 57 billion by 2024. Tetracycline, imidazoles, lincosamides and monoclonal antibodies share large market size. Both broad spectrum and narrow spectrum antibiotics were produced in large scale. Multiple drug-resistant bacterial treatment infection 2017-2025 survey reported that usd26,169 MN in 2016 is expected to increase to USD 060.77 MN by 2025.